Literature DB >> 9253514

Evaluation of i-STAT portable clinical analyzer in a neonatal and pediatric intensive care unit.

J N Murthy1, J M Hicks, S J Soldin.   

Abstract

OBJECTIVE: To evaluate the Point-of-Care (POC) i-STAT system for measuring blood gases (pH, pCO2, pO2) and whole blood electrolytes (sodium, Na+, potassium, K+ and ionized calcium, iCa2+) in the neonatal and pediatric intensive care units. DESIGN AND METHODS: The i-STAT system was evaluated for imprecision, necessity of running quality control and accuracy. Comparison of patients' samples analyzed by the i-STAT system and the Ciba Coming 288 blood gas analyzer were performed. The reliability of the i-STAT system when performed by non-laboratory personnel was assessed.
RESULTS: The system was evaluated for imprecision and linearity using three concentrations of aqueous standards. Except for pO2, the %CVs were < 3.0 for all the analytes (pH, pCO2, Na+, K+ and iCa2+) at all the three concentrations. Using whole blood studies the precision data gave %CVs that were < 3.5 for all the analytes. Linearity studies showed good linearity over the five different concentrations tested. Comparison of the i-STAT and the Ciba Coming 288 blood gas analyzer was assessed by split sample measurement. Patients' results from the i-STAT correlated well with the Ciba Coming 288 blood gas analyzer (r = 0.99 for pH, pCO2 and pO2 and 0.95 to 0.99 for Na+ and K+) with the exception of iCa2+ (r = 0.73). There was no significant difference in the results when operated by PICU/NICU nurses or laboratory personnel. A further study was made to assess whether routine quality control (QC) samples are necessary when using the i-STAT system. The regression analysis (slope and correlation coefficient) of the results from instruments run with and without QC samples gave results close to 1, indicating that there is no need to run additional quality control (QC).
CONCLUSION: The POC testing analyzer i-STAT is a reliable alternative to the traditional blood gas analyzers and provides marginal improvement in turnaround time when compared with the service received from the PICU/NICU laboratory. Costs need to be carefully controlled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253514     DOI: 10.1016/s0009-9120(97)00046-5

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.

Authors:  Tanushree Ganguly; Shorouk Dannoon; Mark R Hopkins; Stephanie Murphy; Hendry Cahaya; Joseph E Blecha; Salma Jivan; Christopher R Drake; Cyril Barinka; Ella F Jones; Henry F VanBrocklin; Clifford E Berkman
Journal:  Nucl Med Biol       Date:  2015-06-09       Impact factor: 2.408

2.  Evaluation of the i-STAT point-of-care analyzer in critically ill adult patients.

Authors:  Jacoline Steinfelder-Visscher; Steven Teerenstra; Jacqueline M T Klein Gunnewiek; Patrick W Weerwind
Journal:  J Extra Corpor Technol       Date:  2008-03

3.  Evaluation of the i-STAT (portable clinical analyser) for measuring haematological parameters in Atlantic cod (Gadus morhua) at different CO2 and temperature conditions.

Authors:  Radoslav S Borissov; Sølvi Espeland; Martin H Iversen
Journal:  Fish Physiol Biochem       Date:  2019-10-03       Impact factor: 2.794

4.  Risk factors for late-onset hyponatremia and its influence on neonatal outcomes in preterm infants.

Authors:  Yoon-Joo Kim; Jin A Lee; Sohee Oh; Chang Won Choi; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

5.  Developing an animal model to detect drug-drug interactions impacting drug-induced respiratory depression.

Authors:  Lin Xu; Ashok Chockalingam; Sharron Stewart; Katherine Shea; Murali K Matta; Suresh Narayanasamy; Nageswara R Pilli; Donna A Volpe; James Weaver; Hao Zhu; Michael C Davis; Rodney Rouse
Journal:  Toxicol Rep       Date:  2020-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.